Cargando…
Economic Burden of Multiple Sclerosis Drugs in Iran during 2011–2019
BACKGROUND: Due to the invariably progressive nature of multiple sclerosis (MS) and the high economic burden of chronic diseases, this study was performed to estimate the economic burden of MS medications in Iran. METHODS: The present research is a descriptive study performed using comprehensive nat...
Autores principales: | Asadollahi, Mina, Darvishi, Ali, Azimi, Amirreza, Annabi, Majid, Jafariazar, Zahra, Heshmat, Ramin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113575/ https://www.ncbi.nlm.nih.gov/pubmed/37089141 http://dx.doi.org/10.18502/ijph.v52i2.11894 |
Ejemplares similares
-
Estimation the medical cost of multiple sclerosis in Iran; 2019–2020
por: Asadollahi, Mina, et al.
Publicado: (2022) -
Economic burden of multiple sclerosis: a cross-sectional study in Iran
por: Rezaee, Mehdi, et al.
Publicado: (2022) -
Economic burden of breast cancer: a case of Southern Iran
por: Jalali, Faride Sadat, et al.
Publicado: (2023) -
The economic burden of coronavirus disease 2019 (COVID-19): evidence from Iran
por: Ghaffari Darab, Mohsen, et al.
Publicado: (2021) -
Significant Increase in the Prevalence of Multiple Sclerosis in Iran in 2011
por: Izadi, Sadegh, et al.
Publicado: (2014)